A team from the Max Planck Research Group for Systems Immunology at the University of Würzburg has identified a previously ...

Triple-negative breast cancer, an aggressive type of breast cancer, accounts for 10% of all breast cancer cases in the United States annually. CD8+ T cells that normally kill cancer cells often become ...

It is well known that when a naive CD8 + T lymphocyte (a sentinel cell circulating in the body) recognizes an infectious agent, it must rapidly create an army of fighting cells to combat the ...

In a study of the immune systems of mice, scientists at Johns Hopkins Medicine say they have found a new role for a protein, ...

The following is a summary of “A gold nanoparticle/peptide vaccine designed to induce SARS-CoV-2-specific CD8 T cells: a double-blind, randomized, phase 1 study in Switzerland,” published in the April ...

CD8 T cells lacking Tet1/3 preferentially differentiate into short-lived effector and effector memory cells following acute ...

A groundbreaking study published in Research (2025, DOI: 10.34133/research.0545) has elucidated the molecular mechanisms by which protein phosphatase 2A (PP2A) regulates CD8+ T cell-mediated immune ...

CERo Therapeutics (CERO) announces the allowance of two patent applications submitted to the U.S. Patent and Trademark Office, USPTO, which ...

Two new studies in Nature report on how effector memory-like CD8 + T cells infiltrate inflamed tissues in various disease states and drive tissue-restricted complement activation via the release ...

Once acquired infection persists for life requiring continuous life long cellular immunity (CD8 memory T cell and IFNγ dependent) for host survival. Development of this response relies on both ...

A phase 3 trial of nemvaleukin alfa in with Keytruda for patients with platinum-resistant ovarian cancer will not continue on ...